Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

iShares Nasdaq Biotechnology ETF (IBB)

257.34
Delayed Data
As of 4:00pm ET
 +1.29 / +0.50%
Today’s Change
240.03
Today|||52-Week Range
400.79
-23.94%
Year-to-Date

Investment Objective

The investment seeks to track the investment results of the NASDAQ Biotechnology Index, which contains securities of NASDAQ  listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by NASDAQ OMX. The fund generally invests at least 90% of its assets in securities of the index and in depositary receipts representing securities of the index. It may invest the remainder of its assets in certain futures, options and swap contracts, cash and cash equivalents, as well as in securities not included in the index. It is non-diversified.

Top and Flop ETFs of 1H
12:05pm / Zacks.com - Paid Partner Content
Forget Stem Cell Stocks: Here Are 3 Clinical-Stage Biotechs to Buy Instead
Jun 28 / MotleyFool.com - Paid Partner Content
Why Galena Biopharma Inc. Is Being Obliterated Today
Jun 29 / MotleyFool.com - Paid Partner Content
A Biotech Stock Turnaround Requires an Alzheimer's Drug Miracle
Jun 27 / TheStreet.com - Paid Partner Content
These 3 Biotechs Are Down More Than 36% This Year, and They're Bargains
Jun 29 / MotleyFool.com - Paid Partner Content
The 5 Best Healthcare ETFs
Jun 26 / MotleyFool.com - Paid Partner Content

Performance

1 month-7.23% 3 years+13.92%
3 months-0.13% 5 years+19.41%
1 year-29.03% Since inception+6.44%
Data through 06/30/2016

Quote Details

Previous close$256.05
Open day’s range253.01 – 257.88
Net asset value (NAV)255.94 (06/29/2016)
Daily volume1,376,058
Average volume (3 months)2,047,404
Data as of 4:00pm ET, 06/30/2016

Peer Comparisonvs. Health ETFs

 IBBCategory
Performance 5-yr return+19.41%+15.78%
Expense Gross exp ratio0.48%0.48%
Risk 5 year sharpe ratio0.990.98
Net assets$6.8B$1.2B
Average market cap$14.4B$36.0B
Average P/E20.924.4
Dividend / Share--0.22%

Competitors

XLV Health Care Select Sector SPDR® Fund
VHT Vanguard Health Care Index Fund ETF Shar...
RYH Guggenheim S&P 500® Equal Weight Health...

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 99.91%
Business service 0.09%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
BIIB Biogen8.15%
AMGN Amgen8.10%
CELG Celgene7.64%
REGN Regeneron Pharmaceuticals7.29%
GILD Gilead Sciences7.29%
VRTX Vertex Pharmaceuticals Inc3.98%
ALXN Alexion Pharmaceuticals Inc3.91%
ILMN Illumina Inc3.52%
MYL Mylan NV3.51%
INCY Incyte Corp3.00%

Partner Offers